Adolescents, both in the US and globally, are a key population affected by HIV, and novel research strategies are needed to prevent, treat, and potentially cure HIV in this vulnerable group. The primary purpose of the Adolescent Health Scientific Working Group (SWG) is to catalyze innovative research by bringing together investigators with interest and experience in addressing the unique issues facing adolescents in HIV treatment, cure, and prevention, including development of biomedical HIV prevention approaches, optimized models for care and treatment, and relevant behavioral and laboratory science. First, we will initiate a monthly research work-in-progress group, to create a peer network and collaborative space for investigation and discovery pertaining to adolescent health and HIV, which will enable scientific mentoring and access to CFAR resources, including the Behavioral Science, Implementation Science, and Developmental Cores, and eHealth SWG. This will efficiently facilitate investigators to develop novel research programs and collaborations pertaining to adolescent health and to access trainee support and funds (Aim 1). Second, by holding skill-building workshops, we will fill gaps in members' knowledge of current methods for adolescent HIV research, and link investigators to timely and innovative approaches to conducting research with adolescents. Our multidisciplinary workshops will incorporate topics related to adolescent medicine, behavioral science, implementation science, and laboratory methods, and will build institutional expertise in novel methodological approaches to HIV research involving adolescents (Aim 2). Third, we will stimulate institutional interest and enthusiasm for the topic of adolescent health and HIV by hosting global leaders in this field as visiting scholars in Seattle (Aim 3). We will disseminate invitations to participate in all activities to CFAR consortium partners, as well as local partners such as the Bill and Melinda Gates Foundation and to our international partners, which will enable circulation of ideas and approaches on defeating HIV among adolescents, creating relevant synergies for both global and domestic HIV research. These comprehensive activities will enable our CFAR members to develop robust research in adolescent HIV prevention and treatment, with cross-disciplinary approaches and multiple institutional collaborations. This SWG will advance HIV science by highlighting research strategies and topics specific to adolescents that are currently under development by HIV researchers and others; SWG researchers will benefit from multiple venues to share experiences and learn from one another. By designing a SWG that focuses on adolescent health, we will ensure that CFAR researchers have opportunities to establish strong collaborations to work with this vulnerable population and promote the adoption of an adolescent-focused research agenda. Our unique strengths in both domestic and global HIV research will allow us to connect adolescent research in both arenas to cross-pollinate ideas, strategies and best practices.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027757-31
Application #
9534846
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
31
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Morgan, Ethan; Skaathun, Britt; Schneider, John A (2018) Sexual, Social, and Genetic Network Overlap: A Socio-Molecular Approach Toward Public Health Intervention of HIV. Am J Public Health 108:1528-1534
Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544
Liu, Amy Y; De Rosa, Stephen C; Guthrie, Brandon L et al. (2018) High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi. Immun Inflamm Dis 6:392-401
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Velonjara, Julia; Crouthamel, Bonnie; O'Malley, Gabrielle et al. (2018) Motherhood increases support for family planning among Kenyan adolescents. Sex Reprod Healthc 16:124-131
Layton, Erik D; Yu, Krystle K Q; Smith, Malisa T et al. (2018) Validation of a CD1b tetramer assay for studies of human mycobacterial infection or vaccination. J Immunol Methods 458:44-52
Murphy, Sean C; Ishizuka, Andrew S; Billman, Zachary P et al. (2018) Plasmodium 18S rRNA of intravenously administered sporozoites does not persist in peripheral blood. Malar J 17:275
Simoni, Jane M; Ronen, Keshet; Aunon, Frances M (2018) Health Behavior Theory to Enhance eHealth Intervention Research in HIV: Rationale and Review. Curr HIV/AIDS Rep 15:423-430
Muthee, Veronica; Bochner, Aaron F; Osterman, Allison et al. (2018) The impact of routine data quality assessments on electronic medical record data quality in Kenya. PLoS One 13:e0195362

Showing the most recent 10 out of 1275 publications